Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6586967 | 0.91 | HTR4 (0.62) | HTR4ACHE | |
| SCHEMBL11545317 | 0.90 | HTR4 (0.78) | HTR4 | |
| Hydrochloric Acid SCHEMBL11552502 | 0.90 | HTR4 (0.76) | HTR4 | |
| Hydrochloric Acid SCHEMBL11551060 | 0.90 | HTR4 (0.76) | HTR4 | |
| Hydrochloric Acid SCHEMBL11544953 | 0.89 | HTR4 (0.77) | HTR4 | |
| Hydrochloric Acid SCHEMBL11544697 | 0.89 | HTR4 (0.77) | HTR4 | |
| SCHEMBL6584868 | 0.89 | HTR4 (0.64) | HTR4ACHE | |
| Hydrochloric Acid SCHEMBL11548799 | 0.89 | HTR4 (0.73) | HTR4 | |
| SCHEMBL6586516 | 0.88 | HTR4 (0.72) | HTR4 | |
| SCHEMBL6583133 | 0.88 | HTR4 (0.75) | HTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1076055-B1 | 1- (1-SUBSTITUTED-4-PIPERIDINYL)METHYL]-4-PIPERIDINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES OF THESE COMPOUNDS | DAINIPPON PHARMACEUTICAL CO (JP) | 2004-11-24 | — | — | EP | disclosed |
| US-6294555-B1 | SEROTONIN HT3 RECEPTOR ANTAGONIST FOR GASTROINTESTINAL DISORDERS | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 2001-09-25 | — | — | US | disclosed |
| EP-1076055-A1 | 1- (1-SUBSTITUTED-4-PIPERIDINYL)METHYL]-4-PIPERIDINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES OF THESE COMPOUNDS | Dainippon Pharmaceutical Co., Ltd. (JP) | 2001-02-14 | — | — | EP | disclosed |